Delivery Order SPE2DB22D1202-SPE2DB23FHPZ3
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $54,934.15 firm fixed-price delivery order is for the supply of MOVANTIK 25 MG TABLET 30S, a prescription medication. The contract has an ultimate completion date of June 24, 2024 and was awarded on June 21, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
- This federal contract award is a delivery order issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,510.92, is for the delivery of the pharmaceutical product Movantik 12.5 mg tablet, with an ultimate completion date of April 10, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of MOVANTIK 25 MG TABLET 30S, a pharmaceutical product. The contract has a firm fixed price ceiling value of $7,015.79 and a period of performance ending on July 14, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of MOVANTIK 25 MG TABLET 30S. The contract has a firm fixed price of $1,177.53 and a completion date of June 27, 2025. The contract is not set aside and was awarded on June 26, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999.00, which provides...
- This federal contract award, valued at $8,763.26, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and...
- This is a $6,470.40 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of MOVANTIK 25 MG TABLET 30S, a pharmaceutical product. The order has an ultimate completion date of August 5, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this contract under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for...
- The Defense Logistics Agency awarded a $9,209.47 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Movantik 25 mg tablets (30-count units), with an ultimate completion date of July 15, 2025. This competitive award, with no set-aside designation, will be performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- This federal contract award to AmerisourceBergen Drug Corp, a pharmaceutical distribution company, is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract valued at $999,999,999. The contract provides a comprehensive range of pharmaceutical and medical supply products, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military healthcare programs globally. The specific...
- This is a Delivery Order federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of MOVIPREP POWDER PACKETS, a medical supply product, with a ceiling value of $1,801.88 and a performance period ending on May 14, 2025. The contract is a Firm Fixed Price arrangement and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Medical Supply Chain. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00, which provides pharmaceutical and medical supply support to military healthcare programs globally. The current Delivery Order is valued at $745,498.26 and is for a firm fixed price, non-set-aside contract to provide a...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB23FHPZ3Delivery Order
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract, a Delivery Order valued at $9,110.52, is for the provision of MOVANTIK 12.5 MG TABLET 30S, a medical product. The contract has an ultimate completion date of May 19, 2023 and uses a Firm Fixed Price pricing type. The award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Cencora, Inc. to deliver a comprehensive range of pharmaceutical products and medical supplies to the DLA in support of military and veteran healthcare programs. This contract award did not utilize any set-aside designations, indicating open competition. Amerisourcebergen Drug Corp, as the prime contractor, is responsible for fulfilling the requirements of this contract, which involves the distribution of essential medical commodities to the DLA and its healthcare facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.1k | 5/18/23 |